Claris Lifesciences’ Arjun Handa, the youngest visitor to Zen Garden, says, in the absence of experience, one can still learn through introspection
Name: Arjun Handa
Profile: MD & CEO, Claris Lifesciences
He says: Frustration in dealing with people is a very dangerous quality to have. If you are ambitious, you need to have the art of dealing with people.
When the right deal comes along, you need to listen to your gut. And the gut is trainable.
You probably do not know him. That is because the man has not been around for that long. At all of 31, he is my youngest visitor ever to the Zen Garden. His grandfather, a Punjabi migrant, came to Ahmedabad in search of work and started life as a worker in a textile mill. His father studied costing and after getting recruited by a young, Gujarati, IIM Ahmedabad alumnus, ended up marrying her. That is how Arjun Handa inherited the best of two great lineages: One strong, ambitious and expansive and risk taking; the other, soft, creative, introspective and emotional.
“For as long as I can remember,” says Arjun, “my father has been trying his hand at things; he has always been an entrepreneur. In 1984, my father and uncle started a pharmaceutical business called Core Healthcare. The company did not do well. It took on a lot of debt and dad and uncle had to sell off the company and they had to split. It left behind a lot of emotional toxicity. Later, dad started Claris. But it remained small and low profile with its own share of struggles.”
After finishing school, Arjun went on to study commerce. After finishing college at 21, he joined Claris as a director. That was exactly 10 years ago. Claris had 45 employees and a turnover of Rs. 35 crore. Arjun worked hard, really hard — sometimes three consecutive shifts to understand how quality could vary when shifts changed. In the injectables business, quality is a matter of life and death. Then one day, he decided to go to Northeastern University in USA to do his MBA. In 2004 he returned, and from then on the real story of Claris starts.
“I focussed on new product development. I had to ramp up people, invest in training, set up clear-cut processes and so on. New product development was my first technical department in Claris and even today, it is the biggest growth driver for Claris. After that, I became the COO and went on to sales. I travelled from Sudan to Sri Lanka, to Africa, US, Europe and understood sales thoroughly and then took it over in totality. Between me and my brother Aditya, we really took over the company. He was the CFO and I was the COO. Growth was our top priority. In 2008, Aditya decided to start his own renewable energy company. Dad moved on and I took on the reins.”
Claris flourished. In the year ending December 2009, sales touched Rs. 759 crore with profits of Rs. 124 crore and its injectable products — from anaesthesia to blood, nutrition to anti-infectives — got to 78 countries, making it a dominant player in the business. But Arjun Handa’s coup was the day he bagged a deal with Pfizer through which his products would now be branded and sold by Pfizer worldwide.
(This story appears in the 16 July, 2010 issue of Forbes India. To visit our Archives, click here.)